Efficacy and safety of Huisheng oral liquid combined with chemotherapy and immunotherapy on advanced non-small cell lung cancer by regulating the PD-1/PD-L1 signaling pathway

ZHAO Weiwei

doi:10.3969/j.issn.1002-7386.2023.23.003

Home>Articles>Efficacy and safety of Huisheng oral liquid combined with chemotherapy and immunotherapy on advanced non-small cell lung cancer by regulating the PD-1/PD-L1 signaling pathway

DOI: 10.3969/j.issn.1002-7386.2023.23.003

Efficacy and safety of Huisheng oral liquid combined with chemotherapy and immunotherapy on advanced non-small cell lung cancer by regulating the PD-1/PD-L1 signaling pathway

ZHAO Weiwei

Keywords：non-small cell lung cancersintilimabchemotherapyHuisheng oral liquidtumor markersurvival periodprogrammed cell death protein 1/programmed cell death ligand 1(PD-1/PD-L1)signaling pathway

Publication Date：2023-12-10

Online Publishing Date：2025-08-15(First online date of this platform, not the publication date of the document)

Pages：6( 3535-3539,3544 )

Hebei Medical Journal

ISTIC

ISSN：1002-7386

Year, Vol.(Issue)：2023,45(23)